###begin article-title 0
MMP19 Is Essential for T Cell Development and T Cell-Mediated Cutaneous Immune Responses
###end article-title 0
###begin p 1
Conceived and designed the experiments: RS. Performed the experiments: RS IB TS RB RM RR KB MM. Analyzed the data: RS IB TS PS RR KB. Contributed reagents/materials/analysis tools: RS. Wrote the paper: RS IB.
###end p 1
###begin p 2
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mmp19</italic>
###xml 670 671 670 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 750 751 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1196 1197 1192 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1200 1201 1196 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
###xml 1016 1020 <span type="species:ncbi:10090">mice</span>
###xml 1292 1296 <span type="species:ncbi:10090">mice</span>
Matrix metalloproteinase-19 (MMP19) affects cell proliferation, adhesion, and migration in vitro but its physiological role in vivo is poorly understood. To determine the function of MMP19, we generated mice deficient for MMP19 by disrupting the catalytic domain of mmp19 gene. Although MMP19-deficient mice do not show overt developmental and morphological abnormalities they display a distinct physiological phenotype. In a model of contact hypersensitivity (CHS) MMP19-deficient mice showed impaired T cell-mediated immune reaction that was characterized by limited influx of inflammatory cells, low proliferation of keratinocytes, and reduced number of activated CD8+ T cells in draining lymph nodes. In the inflamed tissue, the low number of CD8+ T cells in MMP19-deficient mice correlated with low amounts of proinflammatory cytokines, especially lymphotactin and interferon-inducible T cell alpha chemoattractant (I-TAC). Further analyses showed that T cell populations in the blood of immature, unsensitized mice were diminished and that this alteration originated from an altered maturation of thymocytes. In the thymus, thymocytes exhibited low proliferation rates and the number of CD4+CD8+ double-positive cells was remarkably augmented. Based on the phenotype of MMP19-deficient mice we propose that MMP19 is an important factor in cutaneous immune responses and influences the development of T cells.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 327 330 327 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-PageMcCaw1">[1]</xref>
###xml 331 334 331 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Nagase1">[3]</xref>
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that are responsible for processing extracellular matrix (ECM) proteins and a number of cell surface receptors, their ligands, and adhesion molecules. These proteolytical activities have direct impact on cell behavior, proliferation, and survival (reviewed in [1]-[3]).
###end p 4
###begin p 5
###xml 91 94 91 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Sedlacek1">[4]</xref>
###xml 126 129 126 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Cossins1">[5]</xref>
###xml 131 134 131 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Pendas1">[6]</xref>
###xml 513 516 513 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Sedlacek1">[4]</xref>
###xml 517 520 517 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Stracke1">[9]</xref>
###xml 576 579 576 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Cossins1">[5]</xref>
###xml 581 584 581 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Pendas1">[6]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Kolb1">[10]</xref>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Mauch1">[15]</xref>
###xml 1220 1223 1216 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Stracke1">[9]</xref>
###xml 1225 1229 1221 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Sadowski3">[16]</xref>
###xml 1230 1234 1226 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Stracke2">[18]</xref>
###xml 1351 1355 1347 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Sadowski2">[14]</xref>
###xml 1412 1416 1408 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Mauch1">[15]</xref>
###xml 1418 1422 1414 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-vanHorssen1">[19]</xref>
###xml 1510 1514 1506 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Behera1">[20]</xref>
###xml 1515 1519 1511 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Ramanathan1">[22]</xref>
###xml 1831 1835 1827 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Parks1">[23]</xref>
###xml 83 90 <span type="species:ncbi:9606">patient</span>
###xml 136 141 <span type="species:ncbi:9606">Human</span>
###xml 146 152 <span type="species:ncbi:10090">murine</span>
###xml 175 180 <span type="species:ncbi:9606">human</span>
###xml 190 196 <span type="species:ncbi:10090">murine</span>
MMP19 was originally isolated from the inflamed synovium of a rheumatoid arthritis patient [4], from mammary gland, and liver [5], [6]. Human and murine orthologues of MMP19 (human: U37791, murine: AF153199) retain the common domain organization of soluble members of the MMP family, however, they also contain several distinctive features including the insertion of a unique cysteine in the catalytic domain, an altered latency motif, a unique oligoglutamate insertion in the hinge region, and a C-terminal tail [4]-[9]. At the mRNA level, MMP19 is expressed in many tissues [5], [6]. However, the expression at the protein level appears to be more restricted. Vascular smooth muscle cells, myoepithelial cells, and basal keratinocytes express MMP19 constitutively whereas endothelial cells, epithelial cells of the mammary glands, and monocytes show differential regulation of this enzyme [10]-[15]. In addition to its characteristic expression pattern in the vicinity of basement membranes, MMP19 is able to cleave extracellular matrix (ECM) components such as type IV collagen, gamma2 chain of laminin 5, nidogen-1, the large tenascin-C isoform, fibronectin, cartilage oligomeric matrix protein (COMP), and aggrecan [9], [16]-[18]. Moreover, MMP19 effectively cleaves insulin-like growth factor binding protein-3 (IGFBP-3) as we showed previously [14]. MMP19 was also reported to be expressed in macrophages [15], [19] and upregulated under inflammatory conditions such as arthritis and multiple sclerosis [20]-[22]. Recently, it became obvious that beside their role in matrix processing MMPs are important in the development and outcome of inflammatory responses by activating and releasing cytokines, establishing a chemokine gradient, controlling cell migration and survival, and contributing to epidermal barrier function [23].
###end p 5
###begin p 6
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Cavani1">[24]</xref>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Grabbe1">[25]</xref>
###xml 773 774 773 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 782 783 782 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 824 825 824 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 891 892 891 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 969 973 969 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Wang1">[26]</xref>
###xml 974 978 974 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Xu1">[31]</xref>
###xml 983 984 983 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1059 1063 1059 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Cavani1">[24]</xref>
###xml 1065 1069 1065 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Gorbachev1">[32]</xref>
###xml 1071 1075 1071 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Lopez1">[33]</xref>
To reveal specific functions of an MMP in a cutaneous immune response as well as in the epidermis, immune reactions of delayed-type hypersensitivity (DTH) are especially useful due to their well characterized course. Contact hypersensitivity (CHS) represents a subtype of DTH reactions in the skin that is used as model for allergic contact dermatitis mediated by T lymphocytes [24], [25]. Upon cutaneous contact with haptens, small molecules, which act as antigen, T lymphocytes are activated by Langerhans cells, i.e. epidermal dendritic cells (DCs). Antigen-bearing DCs are targeted to regional lymph nodes (LN) and present the antigen to activate and clonally expand specific T cell precursors. During the efferent phase, after secondary exposure to the hapten both CD4+ and CD8+ T cells are recruited into the skin. CD8+ T cells appear to be key effectors of CHS, since depletion of CD8+ T cells reduce CHS while MHC class II-deficiency leads to enhanced response [26]-[31]. CD4+ T cells have a prominent role in the resolution and downregulation of CHS [24], [32], [33].
###end p 6
###begin p 7
###xml 264 268 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Moodycliffe1">[34]</xref>
###xml 269 273 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Nakae2">[38]</xref>
###xml 409 413 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Masuda1">[39]</xref>
###xml 414 418 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Mescher1">[43]</xref>
###xml 789 793 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Nakae2">[38]</xref>
###xml 795 799 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Dilulio1">[44]</xref>
###xml 800 804 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Kelner1">[53]</xref>
Hapten application induces secretion of cytokines by various cell types in the skin. Involvement of interleukin-1 (IL-1), tumor necrosis factor alpha (TNF-alpha), and monocyte chemoattractant protein-1 (MCP-1) during early stage of sensitization has been reported [34]-[38]. For T cell activation and generation of memory T cells promoting cytokines like IL-16, MCP-1, MIF, and IL-2 are of crucial importance [39]-[43]. During the elicitation phase of CHS at the site of hapten challenge, cytokines such as TNF-alpha, interferon-gamma (IFN-gamma), growth-related oncogene-alpha (Gro-alpha), MCP-1, and RANTES (regulated and normal T cell expressed and secreted) recruit neutrophils and eosinophils while lymphotactin and I-TAC are responsible for the activation and recruitment of T cells [38], [44]-[53].
###end p 7
###begin p 8
###xml 457 458 457 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 461 462 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 491 492 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 495 496 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 894 898 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Savino1">[54]</xref>
###xml 948 952 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-VivinusNebot1">[55]</xref>
To exercise a control function in the periphery, effector T cells that are responsible for immune reactions such as CHS have to undergo a proper and accurate development and distribution. In the thymus T lymphocytes develop from early thymocyte progenitors to differentiated, functional T cells that emigrate to the periphery. During their maturation CD4 and CD8 single-positive (SP) mature T lymphocytes develop through differentiation stages involving CD4-CD8- double-negative (DN) and CD4+CD8+ double-positive (DP) thymocytes. DP thymocytes that fail the selection process or are negatively selected die at this stage. Positive selection leads to transition into SP thymocytes and emigration of mature T cells into periphery. Throughout the maturation process thymocytes have to migrate through cortical and medullary regions along ECM components like laminins, fibronectin, and collagen IV [54], which in part is mediated by the action of MMPs [55].
###end p 8
###begin p 9
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mmp19</italic>
###xml 466 467 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 748 749 748 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Wang1">[26]</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Bouloc1">27</xref>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Gocinski1">29</xref>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-SaintMezard1">56</xref>
###xml 994 995 994 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1003 1004 1003 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1075 1076 1075 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1079 1080 1079 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
To analyze the function of MMP19 in vivo mice deficient in mmp19 gene expression were generated via targeted mutagenesis. Since MMP19 is abundantly expressed in the epidermis and is upregulated under inflammatory conditions we focused our investigations onto immune reactions in the skin. To study the effect of MMP19 in T cell-mediated immune responses we used fluorescein isothiocyanate (FITC) as a hapten in the model of CHS and analyzed activation of DCs and CD8+ T cells. We show here that MMP19-deficient mice exhibited a limited inflammatory reaction in response to the hapten marked by lowered cytokine expression, decreased influx of inflammatory cells, low proliferation of keratinocytes, and diminished activation and distribution of CD8+ T cells. Since differences or depletion of T cell subsets could alter the CHS response [26], 27, 29, 56 we further analyzed T cell populations in the blood and thymus under normal unsensitized conditions. Relative numbers of single-positive CD4+ and CD8+ T cells were reduced in the blood and thymus whereas the number of CD4+CD8+ double-positive T cells in the thymus was remarkably augmented. Thus, MMP19 is an important factor, which is necessary for proper immune response in the skin and for development and distribution of T cell populations.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Generation of MMP19-deficient mice
###end title 11
###begin p 12
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mmp19</italic>
###xml 213 220 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g001">Fig. 1A</xref>
###xml 348 361 348 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g001">Fig. 1B and C</xref>
###xml 418 421 418 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 498 501 498 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 522 525 522 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 565 572 565 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g001">Fig. 1D</xref>
###xml 625 628 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 762 769 762 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g001">Fig. 1E</xref>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 684 690 <span type="species:ncbi:10090">murine</span>
###xml 749 754 <span type="species:ncbi:10090">mouse</span>
In order to assess the physiological function of MMP19, we constructed a targeting vector that replaced the catalytic domain with a neoR cassette orientated in the opposite direction to the endogenous mmp19 gene (Fig. 1A). To determine mice carrying the targeting construct Southern blot analysis and PCR of DNA from newborn mice were carried out (Fig. 1B and C). The absence of MMP19 protein in MMP19-deficient (MMP19-/-) mice was demonstrated by immunoblotting of cell lysates prepared from MMP19-/-, heterozygous (MMP19+/-), and wild-type primary keratinocytes (Fig. 1D). The absence of MMP19 at the protein level in MMP19-/- mice was also shown by immunohistochemical analysis of murine skin with antibodies directed against the hinge region of mouse MMP19 (Fig. 1E).
###end p 12
###begin title 13
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Generation of MMP19-/- mice.
###end title 13
###begin p 14
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mmp19</italic>
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Mueller1">[7]</xref>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mmp19</italic>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Tybulewicz1">[70]</xref>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mmp19</italic>
###xml 898 901 898 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stu</italic>
###xml 907 910 907 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 1074 1077 1074 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stu</italic>
###xml 1083 1086 1083 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 36 42 <span type="species:ncbi:10090">murine</span>
###xml 218 223 <span type="species:ncbi:10090">mouse</span>
###xml 1006 1010 <span type="species:ncbi:10090">mice</span>
###xml 1050 1055 <span type="species:ncbi:10090">mouse</span>
###xml 1270 1274 <span type="species:ncbi:10090">mice</span>
###xml 1569 1573 <span type="species:ncbi:10090">mice</span>
###xml 1717 1723 <span type="species:ncbi:10090">murine</span>
###xml 1801 1807 <span type="species:ncbi:10090">murine</span>
(A) Schematic representation of the murine mmp19 gene and its exon/intron-organization as previously described by Mueller et al. [7]; pPNT targeting vector construct, and the resulting deleted active site locus of the mouse mmp19 gene are depicted. The targeting construct based on the pPNT vector [70], was generated by replacement of 1088 bp region of mmp19 gene spanning the end of exon 3 and the whole exon 4 encoding the catalytic domain by the neomycin resistance cassette. Homologous recombination led to introduction of the PGK-Neo cassette and allowed selection of homologous recombinants. The 3'-probe used for detection of replacement events is indicated by thick bars. Also shown are restriction sites used for southern hybridization screening as well as primer binding sites used for diagnostic PCR. Screening for replacement mutants employed restriction digestion of genomic DNA with StuI and EcoRV and southern hybridization with the described 3'-probe. (B) For screening of MMP19-deficient mice Southern blot analyses were performed: mouse DNA digested with StuI and EcoRV was probed with the diagnostic 3'-probe. Probing led to identification of either a 7.3 kb band (wild-type allele, +/+) or a 5 kb band for the targeted allele (-/-). In heterozygous mice (+/-) both alleles are present. (C) Genotyping of targeted alleles using PCR. Wild-type alleles are detected by an 800 bp band, while PCR for the MMP19-deficient allele results in a 600 bp product. (D) Primary keratinocytes isolated from wild-type, heterozygous, and homozygous MMP19-deficient mice were analyzed for MMP19 expression by western blotting using anti-MMP19 antibodies purified against a peptide derived from the hinge region of murine MMP19, that is deteced in size of 59 kD. (E) Immunohistochemical analysis of murine skin with anti-MMP19 antibodies described above. Scale bars: 50 microm.
###end p 14
###begin p 15
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
Mice homozygous for the targeted gene were observed for more than one year. They developed without obvious alteration in gross morphology, weight, size, and fecundity compared to wild-type mice. Breeding mice heterozygous for the targeted gene produced the expected Mendelian ratio of knockout animals of 25%. Thus, MMP19 does not seem to be essential for blastocyst implantation or embryonic development. No apparent changes in the histology of brain, bones, heart, kidney, liver, lung, reproductive organs, pancreas, skin, and spleen of MMP19-deficient mice were seen at 1, 3, 6, and 12 months (data not shown).
###end p 15
###begin title 16
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
MMP19-/- mice exhibit impaired CHS
###end title 16
###begin p 17
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 487 490 487 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 500 503 500 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 753 760 753 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g002">Fig. 2A</xref>
###xml 891 898 891 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g002">Fig. 2A</xref>
###xml 1003 1006 1003 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1042 1045 1042 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1052 1059 1052 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g002">Fig. 2B</xref>
###xml 1280 1283 1280 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1290 1303 1290 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g002">Fig. 2B and C</xref>
###xml 1454 1457 1454 1457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1533 1540 1533 1540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g002">Fig. 2C</xref>
###xml 1623 1627 1623 1627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Sadowski2">[14]</xref>
###xml 1679 1682 1679 1682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1808 1811 1808 1811 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1945 1952 1945 1952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g002">Fig. 2D</xref>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 1007 1011 <span type="species:ncbi:10090">mice</span>
###xml 1046 1050 <span type="species:ncbi:10090">mice</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
###xml 1284 1288 <span type="species:ncbi:10090">mice</span>
###xml 1458 1462 <span type="species:ncbi:10090">mice</span>
###xml 1488 1492 <span type="species:ncbi:10090">mice</span>
###xml 1649 1654 <span type="species:ncbi:10090">mouse</span>
###xml 1697 1701 <span type="species:ncbi:10090">mice</span>
###xml 1812 1816 <span type="species:ncbi:10090">mice</span>
To investigate the role of MMP19 in immune responses MMP19-/- mice and wild-type control mice were studied in a model of CHS. In order to follow up the activation and migration of DCs in the first stage of CHS, FITC was used as a fluorogenic hapten that facilitates the detection of activated DCs, i.e. FITC-positive DCs, in lymph nodes by flow cytometry. No significant differences in the number or activation (CD80, CD86, MHC class II expression) of DCs could be detected between MMP19-/- and MMP19+/+ mice (not shown). After cutaneous sensitization and challenge of the mice by painting FITC on one ear, wild-type mice developed a local inflammatory response that was measured as an increase of ear thickness with a peak around 24 h after challenge (Fig. 2A). This swelling declined slowly during the period of three days. In contrast, ear swelling was abrogated in MMP19-deficient mice (Fig. 2A). Histology of ears 24 h post FITC challenge revealed strong infiltration of inflammatory cells in MMP19+/+ mice that was not observed in MMP19-/- mice (Fig. 2B). The inflammatory reaction in wild-type mice was accompanied by a strongly increased proliferation of keratinocytes resulting in a thickened epidermis. The activation and thickening of the epidermis were absent in MMP19-/- mice (Fig. 2B and C). Evaluation of keratinocytes positive for the proliferation marker Ki-67 showed that 60% of total and basal keratinocytes were proliferating in MMP19+/+ mice while in MMP19-deficient mice only 20% of keratinocytes proliferated (Fig. 2C). Since MMP19 is known to affect keratinocyte proliferation by processing IGFBP-3 [14], we isolated primary mouse keratinocytes from MMP19-/- and wild-type mice and compared their capacity to process IGFBP-3 using western blot analysis. While keratinocytes from MMP19+/- mice exhibited usual degradation of IGFBP-3, keratinocytes deficient for MMP19 showed predominantly the unprocessed form of IGFBP-3 (Fig. 2D).
###end p 17
###begin title 18
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
MMP19-/- mice show impaired ear swelling and inflammatory reaction in CHS.
###end title 18
###begin p 19
###xml 349 352 349 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 765 768 765 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 778 781 778 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1058 1061 1058 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1090 1091 1090 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1309 1310 1309 1310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1358 1361 1358 1361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1371 1374 1371 1374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1491 1494 1491 1494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1795 1798 1795 1798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
###xml 1062 1066 <span type="species:ncbi:10090">mice</span>
###xml 1264 1268 <span type="species:ncbi:10090">mice</span>
###xml 1375 1379 <span type="species:ncbi:10090">mice</span>
###xml 1495 1499 <span type="species:ncbi:10090">mice</span>
###xml 1627 1631 <span type="species:ncbi:10090">mice</span>
###xml 1799 1803 <span type="species:ncbi:10090">mice</span>
###xml 1840 1844 <span type="species:ncbi:10090">mice</span>
(A) Five days after abdominal sensitization with the hapten (FITC), mouse ears were challenged with FITC and ear thickness was measured after 24, 48, and 72 h. Mean values are given in mm as difference to time point 0 h. (B) Hematoxylin-eosin staining of ear sections 24 h after challenge shows reduced influx of neutrophils and eosinophils in MMP19-/- mice. (C) Staining with anti-Ki-67 antibody revealed that proliferation of keratinocytes in MMP19-deficient mice was strongly reduced in basal and suprabasal layers. Ki-67-positive cells were counted and calculated as percentage of basal and total keratinocytes. Six images (magnification 400x) per mice were analyzed. (D) Decreased processing of IGFBP-3 in MMP19-deficient mice. Primary keratinocytes from MMP19+/- and MMP19-/- mice were grown for 72 h and conditioned media were analyzed for IGFBP-3 proteolysis by western blotting. The arrowhead indicates the position of intact IGFBP-3, whereas the arrow points to 30 kD IGFBP-3 proteolytic fragment. (E) Anti-CD8 staining (red) of ear sections. MMP19-/- mice show low numbers of CD8+ T cells in CHS (upper panel) as well as in a T cell-independent model of inflammation, i.e. irritant dermatitis, induced by croton oil (middle panel). Ears of unsensitized mice (lower panel) exhibit low numbers of CD8+ cells; no difference was observed between MMP19+/+ and MMP19-/- mice. CHS and irritant dermatitis were carried out in four independent experiments each with 4 wild-type and 4 MMP19-/- mice. (F) 24 h after FITC challenge ear lysates were analyzed for cytokine expression that was generally reduced in MMP19-deficient mice compared to wild-type animals. (G) Reduced levels of lymphotactin and I-TAC from three independent experiments are shown. Bars in F and G represent values of MMP19-/- mice given as fold decrease to wild-type mice. Significant values with *p<0.05 and **p<0.01; student's t-test. Scale bars: B, 50 microm; C, 20 microm; D, 50 microm.
###end p 19
###begin p 20
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-SaintMezard2">[57]</xref>
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Takeshita1">[58]</xref>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 317 320 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 408 415 408 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g002">Fig. 2E</xref>
###xml 457 458 457 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 475 478 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 691 692 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 766 773 766 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g002">Fig. 2E</xref>
###xml 810 813 810 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 902 903 902 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 566 571 <span type="species:ncbi:10090">mouse</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 814 818 <span type="species:ncbi:10090">mice</span>
Since FITC-stimulated CHS response is mainly mediated by CD8+ T cells [57], [58], we determined the presence of CD8+ cells in ears of wild-type and MMP19-/- mice 24 h after FITC challenge as well as in unsensitized mice. In contrast to wild-type mice with abundantly dispersed CD8+ T cells in the challenged ear MMP19-/- mice showed low numbers of T cells that were comparable to the unsensitized situation (Fig. 2E). To test whether the distribution of CD8+ T cells in MMP19-/- mice differs from that of wild-type mice also under non-T cell-dependent inflammation, mouse ears were treated by a single painting of croton oil as unspecific, inflammatory stimulus. After 24 h, abundance of CD8+ T cells in MMP19-deficient mice was very low compared to wild-type mice (Fig. 2E). These findings indicate that MMP19-/- mice have a defect in T cell-dependent inflammation, keratinocyte proliferation, and CD8+ T cell circulation.
###end p 20
###begin title 21
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
MMP19-/- mice exhibit reduced production of inflammatory cytokines at the site of inflammation
###end title 21
###begin p 22
###xml 165 168 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 241 244 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 319 322 319 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 329 336 329 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g002">Fig. 2F</xref>
###xml 841 844 837 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 851 858 847 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g002">Fig. 2G</xref>
###xml 955 958 951 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
Within inflamed tissues chemokines serve as main attractants for monocytes and T lymphocytes. Using a cytokine antibody array we compared ears of wild-type and MMP19-/- mice for cytokine expression 24 h after FITC challenge. Generally, MMP19-/- mice showed a reduction of all detectable cytokines when compared to MMP19+/+ mice. Fig. 2F shows a representative evaluation of these analyses with highest reduction in lymphotactin (5.1-fold) and IL-12 expression (4.3-fold). Other cytokines such as CD30L, eotaxin, fractalkine, LIX (LPS-induced chemokine), MCP-1, and MCSF (macrophage colony stimulating factor) were moderately reduced. IFN-gamma, IL-4, and IL-5 were not detectable in these assays. Interestingly, lymphotactin and I-TAC, both responsible for activation and recruitment of T cells, showed continuously lower expression in MMP19-/- mice (Fig. 2G). These results correspond with the previous analyses showing low inflammatory response in MMP19-/- mice and point to a biased distribution of T cells at the inflammatory site.
###end p 22
###begin title 23
MMP19-deficiency results in reduced activation of T cells
###end title 23
###begin p 24
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 334 337 334 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 386 387 386 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 396 397 396 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 402 403 402 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 426 433 426 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g003">Fig. 3A</xref>
###xml 669 670 669 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 693 694 693 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 718 719 718 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 816 823 816 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g003">Fig. 3B</xref>
###xml 850 851 850 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 998 999 998 999 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1084 1091 1084 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g003">Fig. 3A</xref>
###xml 1350 1351 1350 1351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1402 1405 1402 1405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1475 1478 1475 1478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1519 1520 1519 1520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1544 1548 1544 1548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1571 1578 1571 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g003">Fig. 3C</xref>
###xml 1621 1624 1621 1624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1682 1683 1682 1683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1709 1712 1709 1712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1768 1769 1768 1769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1798 1799 1798 1799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1818 1825 1818 1825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g003">Fig. 3D</xref>
###xml 1962 1965 1962 1965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
###xml 1172 1176 <span type="species:ncbi:10090">mice</span>
###xml 1406 1410 <span type="species:ncbi:10090">mice</span>
###xml 1493 1497 <span type="species:ncbi:10090">mice</span>
###xml 1625 1629 <span type="species:ncbi:10090">mice</span>
###xml 1713 1717 <span type="species:ncbi:10090">mice</span>
###xml 1980 1984 <span type="species:ncbi:10090">mice</span>
Development of CHS depends on the stimulation and activation of antigen-specific T cells. We analyzed CD8+ T cells in unsensitized and FITC-sensitized mice (i.e. in the afferent phase) as well as in FITC-challenged mice with an active CHS response in the efferent phase, 48 and 72 h after treatment with the hapten. Unsensitized MMP19-/- mice exhibited slightly reduced amounts of CD62L+ and CD25+/CD95+ cells in inguinal LN (Fig. 3A). Cells positive for CD69, CD44, and CD122 showed no differences under unsensitized conditions. 24 h after FITC-sensitization, i.e. abdominal hapten application, wild-type mice showed activation of T cells with increased amount of CD69+ and reduction of CD62L+ cells. In contrast, CD8+ T cells in inguinal lymph nodes of MMP19-deficient mice exhibited generally reduced activation (Fig. 3B). Numbers of activated CD8+ T cells positive for CD62L/CD69, CD44/CD69, and CD44/CD122 were significantly reduced compared to wild-type mice whereas the number of naive CD62L+ cells remained similar to the unsensitized situation indicating lack of activation (Fig. 3A). Five days after FITC sensitization, i.e. after memory T cells were generated, mice ears were challenged with FITC to induce CHS reaction. 24 h after challenge in correlation to the maximal inflammatory ear swelling response, the population of activated CD8+ T cells in the draining lymph nodes (DLN) of MMP19-/- mice was strikingly diminished. Significant differences between MMP19-/- and wild-type mice were observed for CD8+ T cells expressing CD44high, CD44/CD69, and CD25 (Fig. 3C). Although 72 h after FITC challenge MMP19-/- mice did not show any inflammatory signs in the ears, CD8+ T cells in DLN from MMP19-/- mice showed still some differences: the number of CD62L+ cells was increased and CD25+ cells diminished (Fig. 3D). We also analyzed DCs in DLN and observed no significant differences in CD80, CD86, CD40, and MHC class II positive cells between MMP19-/- and wild-type mice (not shown). These results point out a significant role of MMP19 in T cell activation as well as in T cell distribution in peripheral tissues.
###end p 24
###begin title 25
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
MMP19-/- mice exhibit reduced T cell activation in CHS.
###end title 25
###begin p 26
###xml 203 204 203 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 236 239 236 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 320 323 320 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 498 501 498 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 592 595 592 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 716 717 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 743 744 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 777 780 777 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 861 864 861 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1058 1061 1058 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1079 1082 1079 1082 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
###xml 1083 1087 <span type="species:ncbi:10090">mice</span>
Using flow cytometry cells of inguinal (A and B) or draining lymph nodes (C and D) from wild-type (+/+) and MMP19-deficient (-/-) mice were analyzed for the indicated activation markers, all gated on CD8+ T cells. (A) Unsensitized MMP19-/- mice show slight decrease of T cells positive for CD62L and CD95/CD25. (B) MMP19-/- mice analyzed 24 h after abdominal FITC painting (sensitization) exhibit higher numbers of naive T cells (CD62L+) and decreased numbers of activated T cells compared to MMP19+/+ mice. (C) In CHS reaction 48 h after FITC challenge on ears, draining lymph nodes of MMP19-/- mice show significantly reduced numbers of cells positive for activation and memory markers. (D) Reduced numbers of CD25+ and high numbers of CD62L+ cells are still present in MMP19-/- mice after 72 h while other activation markers were comparable to those of MMP19+/+ mice. In A and B two scales are used to match relevant data from an identical experiment. Significant values (p<0.05) are marked by asterisk. Each analysis was carried out four times with MMP19+/+ (n = 4) and MMP19-/- mice (n = 4) per experiment.
###end p 26
###begin title 27
###xml 14 17 14 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
Immature MMP19-/- mice show low numbers of CD4+ and CD8+ T cells in peripheral blood
###end title 27
###begin p 28
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 253 256 253 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 445 448 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 455 468 455 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g004">Fig. 4A and B</xref>
###xml 577 580 577 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 700 703 700 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 788 789 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 797 804 797 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g004">Fig. 4C</xref>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
###xml 890 894 <span type="species:ncbi:10090">mice</span>
Since differences in T cell populations between MMP19-/- and wild-type mice were observed in the periphery and in lymph nodes, we were interested if the T cell population is also biased in the circulation. Blood of immature and mature unsensitized MMP19-/- and wild-type mice were analyzed for the basic cell types. Analyzing T cell subpopulations we observed reduced numbers of CD8+ and CD4+ T cells in the blood of immature (3 weeks old) MMP19-/- mice (Fig. 4A and B) whereas B lymphocytes (B220), monocytes (CD11b), and granulocytes (Ly-6) showed numbers comparable to MMP19+/+ mice. Analysis of 3 months old mice, i.e. adult mice, did not reveal any difference in T cell populations between MMP19-/- and wild-type mice although the latter showed a tendency to increased amounts of CD4+ cells (Fig. 4C). Hence, the MMP19-deficiency influenced T cell proportions in the blood of immature mice.
###end p 28
###begin title 29
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
T cell population in blood of immature MMP19-/- mice is distorted.
###end title 29
###begin p 30
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 236 237 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 245 246 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 294 295 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 303 304 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 329 330 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 466 467 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 475 476 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 597 600 597 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 618 621 618 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
(A) Blood samples of 3-weeks old MMP19+/+ and MMP19-/- mice were analyzed for monocytes, granulocytes (CD11b and Ly-6), B cells (B220), and T cell populations by flow cytometry. MMP19-/- mice exhibit significantly reduced numbers of CD4+ and CD8+ T cells. (B) A typical dot plot analysis of CD4+ and CD8+ populations gated on CD3+ cells in individual mice is shown. (C) No differences in T cell subpopulations were measured in blood of adult mice (12 weeks old). CD4+ and CD8+ T cells shown in A and C are also positive for CD3. Analyses were carried out in five independent experiments with MMP19+/+ (n = 4) and MMP19-/- mice (n = 4). Numbers of B and T lymphocytes were analyzed by gating the lymphocyte region. Significances with *p<0.05; student's t-test.
###end p 30
###begin title 31
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Thymocytes of immature MMP19-/- mice exhibit decreased proliferation and reduced maturation
###end title 31
###begin p 32
###xml 110 113 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 257 258 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 302 303 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 341 354 341 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g005">Fig. 5A and B</xref>
###xml 453 460 453 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g005">Fig. 5C</xref>
###xml 555 558 555 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 565 571 565 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g004">Fig. 4</xref>
###xml 715 722 715 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g006">Fig. 6A</xref>
###xml 759 766 759 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 844 847 844 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 901 904 901 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 911 924 911 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g006">Fig. 6B and C</xref>
###xml 962 965 962 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1029 1030 1029 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1035 1036 1035 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1045 1046 1045 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1100 1107 1100 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g006">Fig. 6C</xref>
###xml 1402 1409 1402 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002343-g006">Fig. 6D</xref>
###xml 1581 1584 1581 1584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1844 1847 1844 1847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
###xml 1264 1268 <span type="species:ncbi:10090">mice</span>
###xml 1334 1338 <span type="species:ncbi:10090">mice</span>
###xml 1600 1604 <span type="species:ncbi:10090">mice</span>
###xml 1848 1852 <span type="species:ncbi:10090">mice</span>
Searching for the origin of biased T cell population in blood, lymph nodes, and in peripheral tissues of MMP19-/- mice we examined subset distribution of T cells in the thymus. Immature MMP19-/- mice at the age of 3-4 weeks exhibit higher numbers of CD4+CD8+ DP cells and reduced levels of CD4+ and CD8+ SP cells compared to wild-type mice (Fig. 5A and B). In contrast, analysis of adult animals showed similar amounts of DP and SP cells in the thymus (Fig. 5C). This observation is in concordance with low amounts of SP T cells in blood of immature MMP19-/- mice (Fig. 4). Furthermore, staining of thymocytes from 3-weeks old animals for the proliferation marker Ki-67 revealed low amounts of proliferating cells (Fig. 6A). These results were also confirmed in vivo by using BrdU incorporation. The incorporation of BrdU in thymocytes of MMP19-/- mice was significantly reduced in comparison to MMP19+/+ mice (Fig. 6B and C). This altered proliferation in MMP19-/- mice was not restricted to particular T cell subsets, since CD3+, CD8+, and CD4+ cells showed a similar degree of BrdU incorporation (Fig. 6C). To get a clue whether these changes could be directly mediated by the lack of MMP19 we studied the morphology of thymi from MMP19-deficient and wild-type mice and the expression of MMP19 using quantitative RT-PCR. Wild-type mice exhibited a low but defined expression of MMP19 in the thymus (Fig. 6D). Thus, MMP19 might be important for defining the thymic microenvironment or for migration of thymocytes among various niches. Analyzing the morphology of thymi from MMP19+/+ and -deficient mice we observed no differences in the cortical and medullar structure (not shown). Formation of the thymic vasculature was not altered, as the expression pattern of VE-cadherin, an endothelial marker, was comparable between wild-type and MMP19-/- mice (not shown). Thus, MMP19 might influence the transition of DP thymocytes to SP mature T cells.
###end p 32
###begin title 33
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Development of single positive lymphocytes in the thymus of MMP19-/- mice is impeded.
###end title 33
###begin p 34
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 182 183 182 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 261 264 261 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 309 310 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 318 319 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 456 459 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 481 484 481 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 494 497 494 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 616 619 616 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 637 640 637 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
Flow cytometry analysis of thymocytes from immature (3-weeks old, A and B) and adult (8-12 weeks, C) MMP19+/+ and MMP19-/- mice. (A) Young MMP19-/- mice have high numbers of CD4+/CD8+ T cells and lower numbers of CD8 single-positive thymocytes compared to MMP19+/+ mice. (B) A typical dot plot analysis of CD4+ and CD8+ T cell populations gated on CD3+ cells shows a decrease of single-positive and accumulation of double-positive T cells in thymi of MMP19-/- mice. (C) Adult MMP19+/+ and MMP19-/- mice show equal numbers of T cell subsets in the thymus. Analyses were done in four independent experiments with MMP19+/+ (n = 4) and MMP19-/- mice (n = 4). Significant values with *p<0.05 and **p<0.01; student's t-test.
###end p 34
###begin title 35
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Thymocytes of MMP19-/- mice exhibit strongly reduced proliferation.
###end title 35
###begin p 36
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 208 209 204 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 214 215 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 224 225 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 335 338 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 358 361 354 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 422 423 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 428 429 424 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 438 439 434 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 461 464 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 530 533 526 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 552 555 548 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 675 678 671 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 764 765 760 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
(A) Immature MMP19-/- mice exhibit low numbers of Ki-67+ medullar cells in the thymus. Scale bars: 50 microm. (B and C). To quantify proliferating thymocytes mice were injected i.p. with BrdU. After 14 h, CD3+, CD4+, and CD8+ thymocytes were analyzed for BrdU incorporation using flow cytometry. Grey, isotype control; light red, MMP19-/- (n = 4); red, MMP19+/+ (n = 4). (C) Quantification of BrdU positive thymocytes. CD3+, CD4+, and CD8+ thymocytes from MMP19-/- mice exhibit markedly diminished proliferation. Black bars: MMP19+/+, white bars: MMP19-/-. (D) Quantitative RT-PCR analysis of MMP19 in the thymus shows expression in WT mice and confirmed the absence in MMP19-/- mice. The expression of MMP19 in the thymus is lower compared to that in the liver. CT, cycle of threshold. Significances with **p<0,01 (student's t-test).
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Pendas2">[59]</xref>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Pendas2">[59]</xref>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Jost1">[60]</xref>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
The present studies show that MMP19 plays a pivotal role during T cell-mediated cutaneous immune response and has an impact on the development of T lymphocytes. MMP19-deficient mice generated by disrupting its catalytic domain show no obvious morphological and developmental abnormalities. This is consistent with the work of Pendas et al. [59] who generated MMP19-deficient mice by replacing the promoter region and exons 1 and 2. Pendas and colleagues studied functions of MMP19 in metabolism, carcinogenesis, and angiogenesis and showed that MMP19-deficient mice are more susceptible for skin tumors and exhibit earlier tumor angiogenesis [59], [60]. We have studied MMP19 in the skin immunity and our results, together with the work on skin tumorigenesis show that MMP19 has indispensable functions in cutaneous homeostasis.
###end p 38
###begin p 39
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Warner1">[61]</xref>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Warner2">[62]</xref>
###xml 935 940 935 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 942 946 942 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Hu1">[63]</xref>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
In the CHS model, the deficiency of MMP19 severely impaired the overall inflammatory response to the hapten suggesting a requirement of this MMP in cutaneous inflammation. A similar reduction of the inflammatory reaction in CHS was described also in stromelysin-1 (MMP3)-deficient mice while the lack of MMP9 resulted in the prolongation of the response. Interestingly, deficiency of MMP3 and MMP9 weakened also the immune reaction in the lung during acute injury although only MMP3 affected the influx of neutrophils [61]. Neutrophils are also controlled by MMP12 as MMP12-deficient mice exhibit a markedly reduced influx of neutrophils into the alveolar space during acute lung injury [62]. In general, the involvement of MMPs in immune reactions is only purely characterized, nevertheless studies with mice deficient in MMP9 and MMP7 showed that MMPs are essential for development of inflammation and its resolution (reviewed in Hu et al. [63]).
###end p 39
###begin p 40
###xml 244 245 244 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 479 482 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
The lack of MMP19 not only considerably reduced the skin inflammation characterized by low influx of inflammatory cells as reported for MMP3-deficiency, but also reduced proliferation of keratinocytes and strikingly diminished activation of CD8+ T cells which are responsible for this type of reaction. This diminished activation was not due to an inability of DCs to migrate into LN and to present the hapten to T cells since the numbers and the activation state of DCs in MMP19-/- and wild-type mice were comparable (not shown) in inguinal draining LNs.
###end p 40
###begin p 41
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 462 463 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 730 734 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Burns1">[47]</xref>
###xml 736 740 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Cole1">[48]</xref>
###xml 742 746 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Tensen1">[52]</xref>
###xml 748 752 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Balabanian1">[64]</xref>
###xml 763 764 759 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 826 829 822 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1221 1224 1217 1220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
###xml 1225 1229 <span type="species:ncbi:10090">mice</span>
With regard to the impaired inflammation it is possible that the amount of proinflammatory factors produced from the epidermis are not sufficient for the attraction and migration of T cells. This is also supported by markedly reduced concentrations of a number of cytokines including lymphotactin and I-TAC. Lymphotactin is a powerful attractant for T cells and is expressed by activated CD8+ T cells and by epidermal dendritic T cells affecting migration of CD8+ T cells. I-TAC, interferon-inducible T cell alpha chemoattractant (also known as CXCL11 or IP-9) that is also produced by keratinocytes binds to the chemokine receptors CXCR7 and CXCR3 and exhibits potent chemoattractant activity for interleukin-2-activated T cells [47], [48], [52], [64]. Since CD8+ T cells were less abundant at the inflammatory sites of MMP19-/- mice than in control mice we suggest that the MMP19-dependent dysregulation of chemokines, such as lymphotactin and I-TAC, is responsible for the skewed distribution and circulation of T cells in the periphery and in LN. Thus, we suppose that proinflammatory factors produced by the inflamed tissue itself could contribute to T cell distribution and the skewed inflammatory reaction in MMP19-/- mice.
###end p 41
###begin p 42
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 239 247 239 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 436 440 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Sadowski2">[14]</xref>
###xml 485 488 485 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 657 660 657 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 747 748 747 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 756 757 756 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 982 985 982 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1025 1026 1025 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1029 1030 1029 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1068 1069 1068 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1112 1113 1112 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 661 665 <span type="species:ncbi:10090">mice</span>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
###xml 986 990 <span type="species:ncbi:10090">mice</span>
###xml 1189 1193 <span type="species:ncbi:10090">mice</span>
###xml 1471 1475 <span type="species:ncbi:10090">mice</span>
The diminished production of inflammatory mediators correlated not only with reduced proliferation of keratinocytes in MMP19-/- mice but also with markedly reduced processing of IGFBP-3 in keratinocytes. In our previous work we could show in vitro that MMP19-dependent proteolysis of IGFBP-3 leads to activation of IGF-signaling pathway and, thus, to increase of proliferation, production of proinflammatory factors, and cell migration [14]. Alterations of the immune response in MMP19-/- mice not only point towards the role of MMP19 in controlling attraction and circulation of inflammatory cells but reveal also an option that T cell populations in MMP19-/- mice might be generally biased. Indeed, the analysis of blood cells disclosed that CD4+ and CD8+ T cell populations are significantly diminished in immature mice. Reduced numbers of cells positive for CD3, CD4, and CD8 in the blood appear to be a direct consequence of the situation in the thymus. Thymi of immature MMP19-/- mice exhibited increased numbers of CD4+CD8+ DP thymocytes while the number of CD8+ T cells was diminished. The numbers of CD4+ T cells were not significantly altered. Thus, thymocytes in immature MMP19 mice exhibit a delayed transition of DP cells into the SP state that is compensated with increased age. This distorted T cell development and biased T cell subpopulations in the blood are most likely not responsible for abrogation of the cutaneous inflammatory reaction since adult mice that were used for experiments did not exhibit these differences. Thus, MMP19 affects the local inflammation independently from developmental alterations of T cells.
###end p 42
###begin p 43
###xml 61 64 61 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Pendas1">[6]</xref>
###xml 344 345 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 348 349 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Haidl1">[65]</xref>
###xml 481 484 481 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 568 569 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 572 573 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 711 715 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-VivinusNebot1">[55]</xref>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Aoudjit1">[66]</xref>
###xml 723 727 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Odaka1">[67]</xref>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-VivinusNebot1">[55]</xref>
###xml 1153 1157 1149 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Sadowski3">[16]</xref>
###xml 1159 1163 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Titz1">[17]</xref>
###xml 1165 1169 1161 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Schroen1">[68]</xref>
###xml 1361 1368 1357 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1802 1806 1798 1802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-VanLint1">[69]</xref>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 1428 1432 <span type="species:ncbi:10090">mice</span>
MMP19 was previously reported to be abundant in human thymus [6] which is in line with its expression in mouse thymi. Although the underlying mechanism of MMP19 function in the thymus is currently not known, former studies with metalloproteinases (MP) inhibitors indicated possible functions of MP. They significantly reduced the numbers of CD4+CD8+ DP and mature SP T cells, inhibited thymocyte proliferation, and led to incomplete upregulation of CD25 (IL-2 receptor) [65]. MMP19-/- mice showed both reduced proliferation of thymocytes and diminished numbers of CD25+CD8+ T cells during sensitization and effector phase of CHS. Although several MMPs are expressed in the thymus their specific role is unknown [55], [66], [67]. It was, however, suggested that MT1-MMP that is upregulated by thymocytes upon contact to laminin 5 contributes to thymocyte migration via releasing CD44 [55]. MMP19 might be also involved in adhesion, detachment, and migration of thymocytes since it processes several ECM proteins including type IV collagen, nidogen-1, and laminin 5 gamma2 that were reported to be relevant for the migration and development of thymocytes [16], [17], [68]. However MMP19 is not the only protease that is able to process these substrates and, thus, cooperation of different MMPs and other proteases may lead to efficient processing of ECM proteins in vivo. The phenotypic changes that were found in MMP19-deficient mice could be rather a result of combined processing of multiple substrates than outcome of one major substrate. Moreover, we cannot exclude that beside IGFBP-3 processing, which is able to affect a number of cellular processes, MMP19 could also process and activate chemokines and proinflammatory cytokines as reported for other MMPs (reviewed in Van Lint P. and Libert C. [69])
###end p 43
###begin p 44
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Altogether, analysis of MMP19-deficient mice revealed that MMP19 plays an important role in the development of the cutaneous immune response, especially in CHS, and is involved in development of T lymphocytes, their distribution, and activation.
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mmp19</italic>
Targeted disruption of the mmp19 gene
###end title 46
###begin p 47
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 345 366 345 366 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GACTTCAGGCTGGAAGATATC</named-content>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 385 403 385 403 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGATTTCTGGTTGAAGGG</named-content>
###xml 513 534 513 534 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCATGGCTCCTGTCTATGCTG</named-content>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NotI</italic>
###xml 553 575 553 575 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAACACCTTTTGATTAACAGGC</named-content>
###xml 661 665 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Tybulewicz1">[70]</xref>
###xml 745 748 745 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stu</italic>
###xml 754 757 754 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 885 906 885 906 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGCTACCCTAAACCAATCAAG</named-content>
###xml 928 949 928 949 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CAGGAATGTGGTATCCAGAAG</named-content>
###xml 1293 1297 1293 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Hogan1">[71]</xref>
###xml 1356 1361 1356 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mmp19</italic>
###xml 1574 1581 1574 1581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1395 1399 <span type="species:ncbi:10090">mice</span>
###xml 1408 1413 <span type="species:ncbi:10090">mouse</span>
###xml 1483 1487 <span type="species:ncbi:10090">mice</span>
###xml 1565 1569 <span type="species:ncbi:10090">mice</span>
The targeting vector was designed to delete 1088 bp from the region spanning the end of exon 3 and the complete exon 4 containing the active site of MMP19. For construction of the 5'-arm of the targeting construct, a 2.8 kb fragment spanning a region including exon 2 and most of exon 3 was amplified from genomic DNA using primers m1U-2/EcoRI (GACTTCAGGCTGGAAGATATC) und m1D-5/EcoRI (AGATTTCTGGTTGAAGGG). The 3'-arm homology region of 2.8 kb ranging from exon 5 to exon 8 was created using primers m1U-25b/XhoI (TCATGGCTCCTGTCTATGCTG) and m1D-31/NotI (GAACACCTTTTGATTAACAGGC). The targeting construct pPNT/mmp19del was introduced into E14 embryonic stem cells [70]. For screening, DNA from G418/Gancyclovir-resistant colonies was digested with StuI and EcoRV and assessed by Southern blotting using a nonoverlapping 3'-probe generated by PCR with primers derived from exon 8 (m1-U30, CGCTACCCTAAACCAATCAAG) and exon 9 (m1D-45, CAGGAATGTGGTATCCAGAAG). The targeting event was confirmed by Southern blot analysis using the strategy described above, i.e. probing with the 3'-probe led to identification of either a 7.3 kb band for the wild type or a 5 kb band for the targeted allele. Two clones, F6 and G5, were microinjected into blastocysts and chimeras were generated by standard techniques [71]. Upon germ line transmission, animals carrying the mutant mmp19 allele were crossed with C57BL/6 mice and two mouse lines (F6 and G5) were established. Studies performed were done with mice backcrossed to C57BL/6 background at least to the F12 generation. Housing of mice and in vivo experiments were performed after approval by the Animal Care Committee of the University of Kiel in compliance with national and institutional guidelines.
###end p 47
###begin title 48
PCR analysis
###end title 48
###begin p 49
###xml 76 95 76 95 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCGCATCTTCAATGTGCCC</named-content>
###xml 153 171 153 171 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GATGCGCAGGTTCACTCC</named-content>
###xml 288 307 288 307 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGATGGATGACGCCACAAG</named-content>
###xml 369 389 369 389 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTTCTATCGCCTTCTTGACG</named-content>
###xml 936 940 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-HeldFeindt1">[72]</xref>
###xml 958 959 934 935 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1011 1015 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-HeldFeindt1">[72]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 862 868 <span type="species:ncbi:10090">murine</span>
Mice were genotyped using PCR. WT allele: forward primer in exon 4 (m1-U10, CCGCATCTTCAATGTGCCC) and a gene-specific reverse primer from exon 5 (mD1-21, GATGCGCAGGTTCACTCC) amplified a 800 bp fragment from the wild-type allele. Targeted allele: forward primer derived from exon 3 (m1-U3, AGATGGATGACGCCACAAG) and a reverse primer based on the PGK-Neo cassette (neofwd, CTTCTATCGCCTTCTTGACG) amplified a 600 bp fragment. Amplification of genomic DNA extracted from tail biopsies was performed using Taq DNA polymerase (Fermentas AB, Vilnius, Lithuania) and a program of 1 min at 95degreesC, followed by 30 cycles at 95degreesC (30 s), 60degreesC (30 s), and 72degreesC (1 min). RNA was isolated with TRIZOL reagent (Invitrogen, Carlsbad, CA). Quantitative PCR was performed using the ABI 7700 Prism Sequence Detection System and TaqMan primer probes specific for murine MMP19 and GAPDH (Applied Biosystems, Foster City, CA) as described [72]. Calculation of CT-values (cycle of threshold) were done as described [72].
###end p 49
###begin title 50
CHS model to FITC and irritant dermatitis to croton oil
###end title 50
###begin p 51
###xml 40 44 40 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Brandt1">[73]</xref>
###xml 46 50 46 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Macatonia1">[74]</xref>
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 318 321 <span type="species:ncbi:9860">Elk</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
CHS was carried out as described before [73], [74]. Briefly, on day 0 shaved mouse abdomens were painted with FITC (Sigma, Steinheim, Germany). After 5 days mice were challenged with FITC on both sides of one ear. Ear thickness was measured before challenge (0 h) and at 24, 48, and 72 h using a micrometer (Mitutoyo, Elk Grove Village, USA). DCs and T cells from draining lymph nodes were isolated 48 and 72 h after challenge and analyzed using flow cytometry. DCs were examined with antibodies against CD11c (BD Biosciences, San Jose, CA), CD80, CD86, and MHCII molecules (Caltag Laboratories, Burlingame). T cells were stained with antibodies against CD8, CD62L, CD69, CD44, CD122, and CD25 (BD Biosciences). DCs and T cells in inguinal lymph nodes were analyzed 24 h after sensitization. The model of irritant dermatitis was performed by application of croton oil (0.8% in acetone) onto mice ears. Ears were analyzed by immunohistochemistry 24 h after painting.
###end p 51
###begin title 52
Immunohistochemistry
###end title 52
###begin p 53
###xml 228 234 <span type="species:ncbi:9986">rabbit</span>
###xml 304 310 <span type="species:ncbi:10090">murine</span>
###xml 708 712 <span type="species:ncbi:9925">goat</span>
###xml 718 721 <span type="species:ncbi:10116">rat</span>
Tissue sections were stained either with eosin and hematoxylin (Gill III, Thermo Shandon, Pittsburgh, PA) or with antibodies. Monoclonal anti-Ki-67 antibodies (clone Tec3, diluted 1:50; Glostrup, Dako Cytomation) and polyclonal rabbit antibodies raised against a peptide derived from the hinge region of murine MMP19 was used. Bound antibodies were detected using the Vectastain ABC Elite kit and AEC as substrate (both Vector Laboratories, Burlingame, CA). For immunofluorescent detection tissues were embedded in tissue freezing medium (Leica Instruments, Nussloch, Germany) and monoclonal anti-CD8 (Chemicon, Temecula, CA) and anti-Ki-67 antibodies were used. Antibodies were detected with Cy3-conjugated goat anti-rat IgG antibodies (Dianova, Hamburg, Germany) and visualized by a BX-50 fluorescence microscope (Olympus, Tokyo, Japan). Images were processed with the Analysis Soft Imaging system (Soft Imaging System, Lakewood, CA).
###end p 53
###begin title 54
Isolation of primary keratinocytes and western blot analysis
###end title 54
###begin p 55
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Caldelari1">[75]</xref>
###xml 217 218 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 294 295 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 353 354 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 410 414 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Sadowski1">[13]</xref>
###xml 416 420 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002343-Sadowski2">[14]</xref>
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
###xml 650 656 <span type="species:ncbi:10090">murine</span>
Primary keratinocytes were isolated from newborn (day 1 to 2) mouse skin by trypsinization using a modified procedure as described previously [75] and grown in plastic vessels coated with type I collagen (10 microg/cm2) in keratinocyte medium (K-SFM) supplemented with EGF, BPE und 0,05 mM CaCl2 (Invitrogen, Carlsbad, CA, USA) at 37degreesC under 5% CO2. At confluency cell lysates were prepared as described [13], [14]. Protein was resolved on 10% SDS-polyacrylamide gels, transferred to PVDF membranes (Macherei-Nagel, Duren, Germany), and analyzed for MMP19 using polyclonal antibodies purified against a peptide derived from the hinge region of murine MMP19. IGFBP-3 processing was examined with polyclonal antibodies detecting full-length form and fragments of IGFBP-3 (Santa Cruz Biotechnologies, CA). Conditioned media of keratinocytes were 10-fold concentrated.
###end p 55
###begin title 56
Detection of cytokine expression
###end title 56
###begin p 57
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse inflammation antibody array (Ray Biotech, Norcross, GA) was used according to the manufacturer's instructions. 24 h after CHS challenge inflamed ears were cut off and lyzed. A 500 microg aliquot of the tissue lysate was used for each array. Signal intensity was evaluated via AIDA Image Analyzer Software (Raytest, Straubenhardt, Germany).
###end p 57
###begin title 58
Isolation and FACS analysis of blood and thymus cells
###end title 58
###begin p 59
###xml 202 203 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 215 216 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 218 219 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 355 360 <span type="species:ncbi:10090">mouse</span>
Mice were anaesthetized and blood was obtained via intracardial punctation. After adding EDTA and washing cells with PBS erythrocytes were lyzed for 15 min at room temperature in lysis buffer (150 mM NH4Cl, 15 mM Na2CO3, 1 mM EDTA, pH 7.5). Thymi were excised immediately after the punctation. Cells were stained with anti-CD3, -CD4, and -CD8 antibodies (mouse T lymphocyte antibody cocktail, BD Biosciences). Blood cells were further stained against CD11b (Caltag), CD45R (B220), and Ly-6C/G (both BD Biosciences). Flow cytometry was carried out using a FACScanto (BD Biosciences).
###end p 59
###begin title 60
Thymocyte proliferation
###end title 60
###begin p 61
###xml 158 162 <span type="species:ncbi:10090">mice</span>
To analyze proliferation by immunohistochemistry, sections of thymi were stained with anti-Ki-67 antibodies as described above. To quantify the proliferation mice were injected i.p. with 1 mg BrdU in 1ml PBS. After 14 h thymocytes were stained with antibodies against CD3, CD4, and CD8 (BD Biosciences). After fixation and permeabilization cells were incubated with FITC-conjugated anti-BrdU antibodies (Santa Cruz Biotechnologies, CA) and analyzed by flow cytometry.
###end p 61
###begin p 62
###xml 76 80 <span type="species:ncbi:10090">mice</span>
We thank K. Bohne for ES cell culture, E. Rhode for generating the knockout mice, I. Konrad and E. Schulz for animal care and for skilful tissue processing. We specially want to express our acknowledgment to Prof. Ulrich Krawinkel who encouraged us to work on the MMP19 project.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
Matrix metalloproteinases and the regulation of tissue remodelling.
###end article-title 64
###begin article-title 65
Inflammation and cancer.
###end article-title 65
###begin article-title 66
Structure and function of matrix metalloproteinases and TIMPs.
###end article-title 66
###begin article-title 67
Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis.
###end article-title 67
###begin article-title 68
###xml 43 48 <span type="species:ncbi:9606">human</span>
Identification of MMP-18, a putative novel human matrix metalloproteinase.
###end article-title 68
###begin article-title 69
###xml 47 52 <span type="species:ncbi:9606">human</span>
Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution.
###end article-title 69
###begin article-title 70
###xml 4 10 <span type="species:ncbi:10090">murine</span>
The murine ortholog of matrix metalloproteinase 19: its cloning, gene organization, and expression.
###end article-title 70
###begin article-title 71
###xml 17 22 <span type="species:ncbi:9606">human</span>
Structure of the human MMP-19 gene. Gene.
###end article-title 71
###begin article-title 72
Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). FEBS Lett.
###end article-title 72
###begin article-title 73
###xml 101 108 <span type="species:ncbi:9606">patient</span>
The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient.
###end article-title 73
###begin article-title 74
Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium.
###end article-title 74
###begin article-title 75
MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours.
###end article-title 75
###begin article-title 76
Matrix metalloproteinase-19 expression in normal and diseased skin: dysregulation by epidermal proliferation.
###end article-title 76
###begin article-title 77
###xml 116 121 <span type="species:ncbi:9606">human</span>
Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3.
###end article-title 77
###begin article-title 78
Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface.
###end article-title 78
###begin article-title 79
Matrix metalloproteinase 19 processes the laminin 5 gamma 2 chain and induces epithelial cell migration.
###end article-title 79
###begin article-title 80
Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1.
###end article-title 80
###begin article-title 81
###xml 56 61 <span type="species:ncbi:9606">human</span>
Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme.
###end article-title 81
###begin article-title 82
Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions.
###end article-title 82
###begin article-title 83
###xml 47 67 <span type="species:ncbi:139">Borrelia burgdorferi</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 89 95 <span type="species:ncbi:10090">murine</span>
Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis.
###end article-title 83
###begin article-title 84
###xml 115 120 <span type="species:ncbi:9606">human</span>
Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes.
###end article-title 84
###begin article-title 85
###xml 103 111 <span type="species:ncbi:9606">patients</span>
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.
###end article-title 85
###begin article-title 86
Matrix metalloproteinases as modulators of inflammation and innate immunity.
###end article-title 86
###begin article-title 87
Effector and regulatory T cells in allergic contact dermatitis.
###end article-title 87
###begin article-title 88
Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity.
###end article-title 88
###begin article-title 89
CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity.
###end article-title 89
###begin article-title 90
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells.
###end article-title 90
###begin article-title 91
Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene.
###end article-title 91
###begin article-title 92
###xml 34 40 <span type="species:ncbi:10090">murine</span>
Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion.
###end article-title 92
###begin article-title 93
Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis.
###end article-title 93
###begin article-title 94
T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.
###end article-title 94
###begin article-title 95
Regulatory role of CD4+ T cells during the development of contact hypersensitivity responses.
###end article-title 95
###begin article-title 96
###xml 80 84 <span type="species:ncbi:10090">mice</span>
CD8+ T cells are the effectors of the contact dermatitis induced by urushiol in mice and are regulated by CD4+ T cells.
###end article-title 96
###begin article-title 97
CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes.
###end article-title 97
###begin article-title 98
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Enhanced contact hypersensitivity in human monocyte chemoattractant protein-1 transgenic mouse.
###end article-title 98
###begin article-title 99
Mast cell-associated TNF promotes dendritic cell migration.
###end article-title 99
###begin article-title 100
IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity.
###end article-title 100
###begin article-title 101
IL-1-induced tumor necrosis factor-alpha elicits inflammatory cell infiltration in the skin by inducing IFN-gamma-inducible protein 10 in the elicitation phase of the contact hypersensitivity response.
###end article-title 101
###begin article-title 102
###xml 30 36 <span type="species:ncbi:10090">murine</span>
The role of interleukin-16 in murine contact hypersensitivity.
###end article-title 102
###begin article-title 103
Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin.
###end article-title 103
###begin article-title 104
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice.
###end article-title 104
###begin article-title 105
IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation.
###end article-title 105
###begin article-title 106
Signals required for programming effector and memory development by CD8+ T cells.
###end article-title 106
###begin article-title 107
Groalpha-mediated recruitment of neutrophils is required for elicitation of contact hypersensitivity.
###end article-title 107
###begin article-title 108
Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity.
###end article-title 108
###begin article-title 109
Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions.
###end article-title 109
###begin article-title 110
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.
###end article-title 110
###begin article-title 111
Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.
###end article-title 111
###begin article-title 112
CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets.
###end article-title 112
###begin article-title 113
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
###end article-title 113
###begin article-title 114
CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).
###end article-title 114
###begin article-title 115
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).
###end article-title 115
###begin article-title 116
Lymphotactin: a cytokine that represents a new class of chemokine.
###end article-title 116
###begin article-title 117
Intrathymic T-cell migration: a combinatorial interplay of extracellular matrix and chemokines?
###end article-title 117
###begin article-title 118
###xml 7 12 <span type="species:ncbi:9606">human</span>
Mature human thymocytes migrate on laminin-5 with activation of metalloproteinase-14 and cleavage of CD44.
###end article-title 118
###begin article-title 119
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Deficient contact hypersensitivity reaction in CD4-/- mice is because of impaired hapten-specific CD8+ T cell functions.
###end article-title 119
###begin article-title 120
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD.
###end article-title 120
###begin article-title 121
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
###end article-title 121
###begin article-title 122
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice.
###end article-title 122
###begin article-title 123
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice.
###end article-title 123
###begin article-title 124
Role of stromelysin 1 and gelatinase B in experimental acute lung injury.
###end article-title 124
###begin article-title 125
The role of metalloelastase in immune complex-induced acute lung injury.
###end article-title 125
###begin article-title 126
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.
###end article-title 126
###begin article-title 127
The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes.
###end article-title 127
###begin article-title 128
Metalloproteinase-dependent control of thymocyte differentiation and proliferation.
###end article-title 128
###begin article-title 129
Gelatinase B (MMP-9) production and expression by stromal cells in the normal and adult thymus and experimental thymic lymphoma.
###end article-title 129
###begin article-title 130
Matrix metalloproteinase-9 in macrophages induces thymic neovascularization following thymocyte apoptosis.
###end article-title 130
###begin article-title 131
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
Interaction of mouse thymocytes and a thymocyte-like cell line with the ECM glycoprotein entactin.
###end article-title 131
###begin article-title 132
Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation.
###end article-title 132
###begin article-title 133
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.
###end article-title 133
###begin article-title 134
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
Manipulating the mouse embryo, 2nd ed.
###end article-title 134
###begin article-title 135
###xml 137 142 <span type="species:ncbi:9606">human</span>
Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.
###end article-title 135
###begin article-title 136
Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo.
###end article-title 136
###begin article-title 137
Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate.
###end article-title 137
###begin article-title 138
###xml 21 27 <span type="species:ncbi:10090">murine</span>
Long-term culture of murine epidermal keratinocytes.
###end article-title 138
###begin p 139
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 139
###begin p 140
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants SE 878/2-1 and SFB617-A8 (R.S.) from DFG. The findings and conclusions of this report are those of the authors and do not represent the views of DFG. The authors have no conflicting financial interests.
###end p 140

